EVH
Income statement / Annual
Last year (2024), Evolent Health, Inc.'s total revenue was $2.55 B,
an increase of 30.09% from the previous year.
In 2024, Evolent Health, Inc.'s net income was -$61.62 M.
See Evolent Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$2.55 B |
$1.96 B |
$1.35 B |
$907.96 M |
$1.02 B |
$846.38 M |
$627.06 M |
$434.95 M |
$254.19 M |
$96.88 M |
| Cost of Revenue |
$2.19 B
|
$1.50 B
|
$1.04 B
|
$657.55 M
|
$701.37 M
|
$513.06 M
|
$327.83 M
|
$269.35 M
|
$155.18 M
|
$57.40 M
|
| Gross Profit |
$367.35 M
|
$460.47 M
|
$316.58 M
|
$250.41 M
|
$321.06 M
|
$333.32 M
|
$299.24 M
|
$165.60 M
|
$99.01 M
|
$39.48 M
|
| Gross Profit Ratio |
0.14
|
0.23
|
0.23
|
0.28
|
0.31
|
0.39
|
0.48
|
0.38
|
0.39
|
0.41
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$27.00 M
|
$15.50 M
|
$15.10 M
|
$19.80 M
|
$18.20 M
|
$17.20 M
|
$11.10 M
|
$5.80 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$219.50 M
|
$310.55 M
|
$392.82 M
|
$306.31 M
|
$205.67 M
|
$160.69 M
|
$75.29 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$263.05 M
|
$358.11 M
|
$269.27 M
|
$219.50 M
|
$310.55 M
|
$392.82 M
|
$306.31 M
|
$205.67 M
|
$160.69 M
|
$75.29 M
|
| Other Expenses |
$144.79 M
|
$173.57 M
|
$67.20 M
|
$60.04 M
|
$61.48 M
|
$60.91 M
|
$109,000.00
|
$171,000.00
|
$4,000.00
|
$7.17 M
|
| Operating Expenses |
$407.84 M
|
$531.68 M
|
$336.46 M
|
$279.54 M
|
$372.03 M
|
$453.73 M
|
$350.82 M
|
$238.04 M
|
$177.92 M
|
$82.45 M
|
| Cost And Expenses |
$2.60 B
|
$2.04 B
|
$1.37 B
|
$937.09 M
|
$1.07 B
|
$966.79 M
|
$678.65 M
|
$507.39 M
|
$333.09 M
|
$139.85 M
|
| Interest Income |
$5.54 M
|
$5.26 M
|
$1.37 M
|
$407,000.00
|
$3.16 M
|
$3.99 M
|
$3.44 M
|
$1.66 M
|
$0.00
|
$0.00
|
| Interest Expense |
$24.72 M
|
$54.21 M
|
$15.57 M
|
$25.43 M
|
$28.34 M
|
$14.53 M
|
$5.48 M
|
$3.64 M
|
$723,000.00
|
$293,000.00
|
| Depreciation & Amortization |
$118.37 M
|
$123.42 M
|
$90.25 M
|
$60.04 M
|
$60.84 M
|
$66.64 M
|
$44.52 M
|
$32.37 M
|
$17.22 M
|
$7.17 M
|
| EBITDA |
$80.06 M |
-$24.79 M |
$43.75 M |
$55.66 M |
-$241.38 M |
-$245.95 M |
-$4.15 M |
-$40.40 M |
-$220.31 M |
-$31.51 M |
| EBITDA Ratio |
0.03
|
-0.01
|
0.01
|
0.1
|
0.02
|
-0.08
|
-0.01
|
-0.09
|
0.38
|
-4.64
|
| Operating Income Ratio |
-0.02
|
-0.04
|
-0.04
|
0.03
|
-0.04
|
-0.14
|
-0.08
|
-0.17
|
-0.93
|
-0.44
|
| Total Other Income/Expenses Net |
-$22.55 M
|
-$131.19 M
|
-$65.72 M
|
$12.61 M
|
-$67.69 M
|
-$18.23 M
|
-$6.67 M
|
-$3.56 M
|
-$114,000.00
|
$386.26 M
|
| Income Before Tax |
-$63.04 M
|
-$202.41 M
|
-$62.08 M
|
-$29.80 M
|
-$337.80 M
|
-$327.12 M
|
-$54.15 M
|
-$76.40 M
|
-$237.53 M
|
$343.29 M
|
| Income Before Tax Ratio |
-0.02
|
-0.1
|
-0.05
|
-0.03
|
-0.33
|
-0.39
|
-0.09
|
-0.18
|
-0.93
|
3.54
|
| Income Tax Expense |
-$1.41 M
|
-$89.37 M
|
-$43.38 M
|
$483,000.00
|
-$3.55 M
|
-$21.54 M
|
$40,000.00
|
-$6.64 M
|
-$10.76 M
|
$23.48 M
|
| Net Income |
-$61.62 M
|
-$113.04 M
|
-$18.70 M
|
-$30.28 M
|
-$334.25 M
|
-$305.58 M
|
-$52.66 M
|
-$60.67 M
|
-$159.74 M
|
$332.49 M
|
| Net Income Ratio |
-0.02
|
-0.06
|
-0.01
|
-0.03
|
-0.33
|
-0.36
|
-0.08
|
-0.14
|
-0.63
|
3.43
|
| EPS |
-0.81 |
-1.28 |
-0.2 |
-0.35 |
-3.94 |
-3.71 |
-0.68 |
-0.94 |
-3.55 |
13.14 |
| EPS Diluted |
-0.81 |
-1.28 |
-0.2 |
-0.35 |
-3.94 |
-3.71 |
-0.68 |
-0.94 |
-3.55 |
6.93 |
| Weighted Average Shares Out |
$114.68 M
|
$111.25 M
|
$93.70 M
|
$86.07 M
|
$84.93 M
|
$82.36 M
|
$77.34 M
|
$64.35 M
|
$45.00 M
|
$25.13 M
|
| Weighted Average Shares Out Diluted |
$114.68 M
|
$111.25 M
|
$93.70 M
|
$86.07 M
|
$84.93 M
|
$82.36 M
|
$77.34 M
|
$64.35 M
|
$45.03 M
|
$46.14 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
